全文获取类型
收费全文 | 14766篇 |
免费 | 1186篇 |
国内免费 | 803篇 |
出版年
2023年 | 164篇 |
2022年 | 209篇 |
2021年 | 718篇 |
2020年 | 467篇 |
2019年 | 601篇 |
2018年 | 572篇 |
2017年 | 410篇 |
2016年 | 581篇 |
2015年 | 859篇 |
2014年 | 965篇 |
2013年 | 1086篇 |
2012年 | 1316篇 |
2011年 | 1202篇 |
2010年 | 753篇 |
2009年 | 663篇 |
2008年 | 754篇 |
2007年 | 697篇 |
2006年 | 595篇 |
2005年 | 520篇 |
2004年 | 459篇 |
2003年 | 371篇 |
2002年 | 336篇 |
2001年 | 310篇 |
2000年 | 253篇 |
1999年 | 229篇 |
1998年 | 147篇 |
1997年 | 145篇 |
1996年 | 147篇 |
1995年 | 112篇 |
1994年 | 112篇 |
1993年 | 82篇 |
1992年 | 135篇 |
1991年 | 103篇 |
1990年 | 78篇 |
1989年 | 79篇 |
1988年 | 64篇 |
1987年 | 72篇 |
1986年 | 64篇 |
1985年 | 50篇 |
1984年 | 48篇 |
1983年 | 41篇 |
1982年 | 24篇 |
1981年 | 13篇 |
1980年 | 16篇 |
1979年 | 19篇 |
1977年 | 14篇 |
1976年 | 11篇 |
1975年 | 9篇 |
1973年 | 10篇 |
1972年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Single Cell Transcriptome Amplification with MALBAC 总被引:1,自引:0,他引:1
2.
ObjectiveWe investigated whether glutamate, NMDA receptors, and eukaryote elongation factor-2 kinase (eEF-2K)/eEF-2 regulate P-glycoprotein expression, and the effects of the eEF-2K inhibitor NH125 on the expression of P-glycoprotein in rat brain microvessel endothelial cells (RBMECs).MethodsCortex was obtained from newborn Wistar rat brains. After surface vessels and meninges were removed, the pellet containing microvessels was resuspended and incubated at 37°C in culture medium. Cell viability was assessed by the MTT assay. RBMECs were identified by immunohistochemistry with anti-vWF. P-glycoprotein, phospho-eEF-2, and eEF-2 expression were determined by western blot analysis. Mdr1a gene expression was analyzed by RT-PCR.ResultsMdr1a mRNA, P-glycoprotein and phospho-eEF-2 expression increased in L-glutamate stimulated RBMECs. P-glycoprotein and phospho-eEF-2 expression were down-regulated after NH125 treatment in L-glutamate stimulated RBMECs.ConclusionseEF-2K/eEF-2 should have played an important role in the regulation of P-glycoprotein expression in RBMECs. eEF-2K inhibitor NH125 could serve as an efficacious anti-multidrug resistant agent. 相似文献
3.
4.
Zhenya Lu Furong Liu Linglin Chen Huadan Zhang Yuemin Ding Jianxiang Liu Michael Wong Ling-Hui Zeng 《PloS one》2015,10(8)
Mammalian target of rapamycin (mTOR) regulates cell growth, cell differentiation and protein synthesis. Rapamycin, an inhibitor of mTOR, has been widely used as an immunosuppressant and anti-cancer drug. Recently, mTOR inhibitors have also been reported to be a potential anti-epileptic drug, which may be effective when used in young patients with genetic epilepsy. Thus, a suitable dose of rapamycin which can maintain the normal function of mTOR and has fewer side effects ideally should be identified. In the present study, we first detected changes in marker proteins of mTOR signaling pathway during development. Then we determined the dose of rapamycin by treating rats of 2 weeks of age with different doses of rapamycin for 3 days and detected its effect on mTOR pathway. Young rats were then treated with a suitable dose of rapamycin for 4 weeks and the effect of rapamycin on mTOR, development and immunity were investigated. We found that the expression of the marker proteins of mTOR pathway was changed during development in brain hippocampus and neocortex. After 3 days of treanent, 0.03 mg/kg rapamycin had no effect on phospho-S6, whereas 0.1, 0.3, 1.0 and 3.0 mg/kg rapamycin inhibited phospho-S6 in a dose-dependent manner. However, only 1.0 mg/kg and 3.0 mg/kg rapamycin inhibited phospho-S6 after 4 weeks treatment of rapamycin. Parallel to this result, rats treated with 0.1 and 0.3 mg/kg rapamycin had no obvious adverse effects, whereas rats treated with 1.0 and 3.0 mg/kg rapamycin showed significant decreases in body, spleen and thymus weight. Additionally, rats treated with 1.0 and 3.0 mg/kg rapamycin exhibited cognitive impairment and anxiety as evident by maze and open field experiments. Furthermore, the content of IL-1β, IL-2, IFN-γ, TNF-α in serum and cerebral cortex were significantly decreased in 1.0 and 3.0 mg/kg rapamycin-treated rats. The expression of DCX was also significantly decreased in 1.0 and 3.0 mg/kg rapamycin-treated rats. However, rats treated with 1.0 mg/ kg rapamycin exhibited fewer and milder side effects than those treated with 3.0 mg/kg. In summary, all these data suggest that there is not a rapamycin dose that can inhibit mTOR for epilepsy without causing any side effects, but 1 mg /kg may be the optimal dose for young rats for suppressing mTOR with relatively few side effects. 相似文献
5.
Yan Xue Liu Jia Wu Ke-Xin Yang Nan Pan Li-Ben Song Ying Liu Yang Tang Zhong-Hua 《Journal of Plant Growth Regulation》2022,41(6):2421-2434
Journal of Plant Growth Regulation - Early-spring plants are a special type of plant that complete their life cycle promptly in cold, early spring. Very little effort has been made into researching... 相似文献
6.
7.
8.
Glycoprotein O (gO) is conserved among betaherpesviruses, but little is known about the maturation process of gO in human herpesvirus 6 (HHV-6). We found that HHV-6 gO maturation was accompanied by cleavage of its carboxyl terminus and required coexpression of gH and gL, which promoted the export of gO out of the endoplasmic reticulum (ER). Finally, we also found that gO was not required for HHV-6A growth in T cells. 相似文献
9.
10.
Hong Tang 《中国科学:生命科学英文版》2016,59(4):434-435
正How Ebola virus(EBOV)enters a host cell remains intriguingly mysterious to the public.Recently,a study led by George F Gao and his colleagues has unveiled how the primed glycoprotein on the envelope of EBOV binds to its endosomal receptor Niemann-Pick C1(NPC1)molecule during the process of virus membrane fusion with the host cells,an essential step for viral entry(Wang et al.,2016).This fine resolution of the viral glycoprotein with NPC1 at the atomic level sheds light on the development of therapeutic inhibitors against EBOV infection. 相似文献